220 related articles for article (PubMed ID: 25371393)
1. HepaRG cells as human-relevant in vitro model to study the effects of inflammatory stimuli on cytochrome P450 isoenzymes.
Rubin K; Janefeldt A; Andersson L; Berke Z; Grime K; Andersson TB
Drug Metab Dispos; 2015 Jan; 43(1):119-25. PubMed ID: 25371393
[TBL] [Abstract][Full Text] [Related]
2. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
[TBL] [Abstract][Full Text] [Related]
3. A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells.
Klein M; Thomas M; Hofmann U; Seehofer D; Damm G; Zanger UM
Drug Metab Dispos; 2015 Feb; 43(2):273-83. PubMed ID: 25480923
[TBL] [Abstract][Full Text] [Related]
4. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
[TBL] [Abstract][Full Text] [Related]
6. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes.
Kudo T; Endo Y; Taguchi R; Yatsu M; Ito K
Xenobiotica; 2015 May; 45(5):413-9. PubMed ID: 25470432
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture.
Dickmann LJ; Patel SK; Rock DA; Wienkers LC; Slatter JG
Drug Metab Dispos; 2011 Aug; 39(8):1415-22. PubMed ID: 21555507
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
[TBL] [Abstract][Full Text] [Related]
11. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
Cho YY; Jeong HU; Kim JH; Lee HS
Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD28 monoclonal antibody-stimulated cytokines released from blood suppress CYP1A2, CYP2B6, and CYP3A4 in human hepatocytes in vitro.
Czerwiński M; Kazmi F; Parkinson A; Buckley DB
Drug Metab Dispos; 2015 Jan; 43(1):42-52. PubMed ID: 25326287
[TBL] [Abstract][Full Text] [Related]
13. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
14. The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes.
Febvre-James M; Bruyère A; Le Vée M; Fardel O
Drug Metab Dispos; 2018 Feb; 46(2):131-140. PubMed ID: 29162613
[TBL] [Abstract][Full Text] [Related]
15. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor.
Darnell M; Schreiter T; Zeilinger K; Urbaniak T; Söderdahl T; Rossberg I; Dillnér B; Berg AL; Gerlach JC; Andersson TB
Drug Metab Dispos; 2011 Jul; 39(7):1131-8. PubMed ID: 21436404
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.
Sugiyama I; Murayama N; Kuroki A; Kota J; Iwano S; Yamazaki H; Hirota T
Xenobiotica; 2016 Sep; 46(9):765-74. PubMed ID: 26711482
[TBL] [Abstract][Full Text] [Related]
18. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
[TBL] [Abstract][Full Text] [Related]
20. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells.
Le Vée M; Bruyère A; Jouan E; Fardel O
Int Immunopharmacol; 2020 Jun; 83():106439. PubMed ID: 32234672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
